Advertisement
Screener

Royalty Pharma plc (RPRX) ROE

Royalty Pharma plc (RPRX) ROE

  • 2026-06-30: ROE 8.33%.
  • 2026-03-31: ROE 8.35%.
  • 2025-12-31: ROE 7.97%.
  • 2025-09-30: ROE 7.98%.

Complete source-backed roe history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-308.33%
2026-03-318.35%
2025-12-317.97%
2025-09-307.98%
2025-06-3010.78%
2025-03-3111.18%
2024-12-318.31%
2024-09-3011.16%
2024-06-306.90%
2024-03-318.10%
2023-12-3111.25%
2023-09-301.92%
2023-06-302.60%
2023-03-313.38%
2022-12-310.45%
2022-09-304.87%
2022-06-304.48%
2022-03-315.94%
2021-12-316.05%
2021-09-307.54%
2021-06-309.34%
2021-03-319.89%
2020-12-3114.35%
2020-09-3013.47%
2020-06-3026.07%
2020-03-3128.65%

Annual ROE

DateROE
2025-12-317.94%
2024-12-318.31%
2023-12-3111.25%
2022-12-310.45%
2021-12-316.05%
2020-12-319.85%
2019-12-3138.24%
2018-12-3130.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80